{"id":"W3039230543","doi":"10.1182/bloodadvances.2019001212","title":"Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Oncology; Internal medicine; Phases of clinical research; Phase (matter); Clinical trial; Bone marrow; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001711897,0.001165368,0.002383281,0.0005213219,0.0002954376,0.0006499242,0.0008122722,0.001063865,0.002039903],"category_scores_gemma":[0.0008170385,0.0005460695,0.0009768538,0.000276513,0.0006348145,0.0006719233,0.0002700874,0.001858055,0.0005171364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006427878,"about_ca_system_score_gemma":0.0007781687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003237987,"about_ca_topic_score_gemma":0.001102864,"domain_scores_codex":[0.9993402,0.000400762,0.00003237502,0.00008665658,0.00007841553,0.00006149045],"domain_scores_gemma":[0.9995071,0.00009078916,0.0001153369,0.0000398968,0.00003748136,0.0002093454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5701911,0.08973455,0.009959963,0.000991628,0.002113481,0.000651149,0.000303347,0.004391871,0.1416864,0.0002985888,0.003069673,0.1766082],"study_design_scores_gemma":[0.2877701,0.6713624,0.02111942,0.00005005106,0.0007112648,0.0009461989,0.00006041122,0.003478779,0.01176486,0.0001602444,0.002515041,0.00006122397],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960648,0.001924787,0.0004010758,0.0002080202,0.00003151353,0.0004835478,0.0002468773,0.00006085512,0.0005784805],"genre_scores_gemma":[0.9949669,0.001196226,0.001239482,0.0003879462,0.000100772,0.0006446133,0.0007036815,0.00001980892,0.0007404553],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002383281,"threshold_uncertainty_score":0.009053469,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02551998463829878,"score_gpt":0.3188262696074818,"score_spread":0.293306284969183,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}